Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stabilized and preserved ketoifen ophthalmic compositions

a technology of ophthalmic compositions and stabilized ketoifen, which is applied in the field of ophthalmic compositions, can solve the problems of chemical or drug substances that are not compatible with hydrogen peroxide and susceptible to chemical oxidation

Inactive Publication Date: 2008-08-28
TSAO FU PAO +2
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The patent describes an eye drop solution that contains a drug called ketotifen salt and a small amount of hydrogen peroxide. The solution also contains other substances that help stabilize the ketotifen salt and prevent it from being oxidized by the hydrogen peroxide. The solution is meant to help treat and prevent allergic conjunctivitis, a common eye condition. The technical effect of this solution is to provide a more effective treatment for allergic conjunctivitis that helps stabilize the ketotifen salt and prevent it from oxidizing."

Problems solved by technology

Many chemical or drug substances are not compatible with hydrogen peroxide, i.e., are susceptible to chemical oxidation by hydrogen peroxide.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0032]

TABLE 1Ketotifen-Perborate FormulationNaKetotifenPerborate•BoricNaFumarateNaCl4 H2ODequestAcidBorateFormulation(mg / mL)pH(mg / mL)(mg / mL)(mg / mL)(mg / mL)(mg / mL)10.3456.36.650.270.065.00.05206.36.650.270.065.00.05305.36.650.270.065.00.0540.3455.36.650.20.065.00.05

[0033]The stability of the formulations shown in Table 1 are evaluated by filling the formulations in bottles and storing the formulations at 55° C. for various times. The results are summarized in Table 2 below.

TABLE 2Ketotifen Fumarate Concentrations (mg / mL) of Samples Filledin Polypropylene Bottles and Stored at 55° C.1 Week2 Weeks4 WeeksFormulationInitialat 55° C.at 55° C.at 55° C.10.3400.3190.3230.29620.000.000.000.0030.000.000.000.0040.3360.3370.3420.341

[0034]The formulations listed in Table 2 met USP preservative effectiveness test criteria as required by FDA for the preservation of ophthalmic solutions.

[0035]The results as shown in Table 2 indicate that ketotifen is stable under evaluated conditions, especially form...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
ophthalmic compositionaaaaaaaaaa
pHaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

Ophthalmic compositions comprising ketotifen and a source of hydrogen peroxide providing an amount of hydrogen peroxide of from about 0.001 to about 0.1% (w / v) of hydrogen peroxide, and methods for the treatment and prevention of allergic conjunctivitis using these compositions are provided herein.

Description

BACKGROUND OF THE INVENTION[0001]The present invention relates to ophthalmic compositions comprising ketotifen as a pharmaceutically active agent and a source of hydrogen peroxide as a preservative for use in treating allergic conjunctivitis. U.S. Pat. Nos. 5,725,887 (the '887 patent) and 5,607,698, and application Ser. No. 11 / 078,209, all of which are expressly incorporated by reference herein in their entirety, disclose and claim methods for the preservation of ophthalmic solutions using stabilized hydrogen peroxide and compositions so preserved. However, hydrogen peroxide is a strong oxidation agent. Many chemical or drug substances are not compatible with hydrogen peroxide, i.e., are susceptible to chemical oxidation by hydrogen peroxide. Ketotifen is a pharmaceutically active agent susceptible to chemical oxidation by hydrogen peroxide. While ketotifen is not compatible with low concentrations of hydrogen peroxide when formulated at neutral pH, i.e., a pH of about 7, it has now...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/44A61P27/14
CPCA61K31/4535A61K9/0048A61P27/02A61P27/14A61K9/08A61K47/02
Inventor TSAO, FU-PAOWONG, MICHELLEYEN, SHAU-FONG
Owner TSAO FU PAO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com